Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In 2024, 44% of all large employers covered GLP-1 drugs for obesity, up from 41% in 2023, according to Mercer, a benefits consultant
Fourth, long-term clinical outcomes data - cirrhosis incidence, HCC rates, liver transplantation, and liver-related mortality assessed as primary endpoints in randomized trials - are not yet available and are urgently needed to move beyond surrogate histological endpoints
(And leave your email too, so we can let you know if we write an article based on your suggestion.) Last updated on Dec 05, 2025
The Precision Peptide Genetic Test ($298) maps 14 metabolic pathways and 150+ genetic insights, allowing PlexusDx to customize your weekly protocol without changing cost or frequency
US$ 27.58
US$ 29.62
US$ 28.74
